Nasdaq-100 Welcomes Rocket Lab, Astera Labs, CoreWeave, Nebius & Teradyne
Charter (CHTR), Cognizant (CTSH), Insmed (INSM), Verisk (VRSK) and Zscaler (ZS) will be removed from the Nasdaq-100 Index effective June 22, 2026.
Charter (CHTR), Cognizant (CTSH), Insmed (INSM), Verisk (VRSK) and Zscaler (ZS) will be removed from the Nasdaq-100 Index effective June 22, 2026.
Adobe reported strong Q2 results and raised its full-year guidance, but shares fell after the company announced that CFO Dan Durn will step down on June 15 to pursue a new opportunity.
TeraWulf, Cipher Digital, Hut 8, and Fluidstack secure major Anthropic leases backed by Google in a landmark $35 billion financing package.
Adial Pharmaceuticals acquires Azora Therapeutics and raises up to $64 million to advance AT177, a novel colon-targeted therapy for ulcerative colitis. Phase 1 studies planned for mid-2027.
Analysts initiate coverage with Buy ratings on Sensei (SNSE), Septerna (SEPN), Kazia (KZIA), NervGen (NGEN), and Sutro (STRO).
Beijing targets misleading 618 deals by JD, PDD, Alibaba; stocks fall as regulators curb subsidy wars and unclear discounts.